Concord medical announces receipt of nyse non-compliance letter regarding ads trading price

Beijing , feb. 20, 2024 /prnewswire/ -- concord medical services holdings limited ("concord medical" or the "company") (nyse: ccm), a healthcare provider specialized in cancer treatment, research, education and prevention in china, today announced that it has received a letter (the "letter") from the new york stock exchange (the "nyse") dated february 12, 2024, notifying the company that it is below compliance standards due to the trading price of the company's american depositary shares (the "adss") and that the applicable cure period for the company to regain compliance expires on august 12, 2024. pursuant to applicable nyse continued listing standards, a company would be considered "below criteria" by the nyse if the average closing price of a security as reported on the consolidated tape is less than $1.00 over a consecutive 30 trading-day period.
CCM Ratings Summary
CCM Quant Ranking